Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5LGr vs Tiapride vs Placebo in Pediatric Tic Disorder
NCT01501695Phase 3Completed
- Sponsor
- Tasly Group
- Start
- Jan 2008
- Primary completion
- Nov 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of wulingshen in tic disorder, Tourette syndrome (TS), chronic tic disorder, sponsored by Tasly Group. Started Jan 2008; status: completed.
02
Drugs
wulingshen
03
Conditions
tic disorderTourette syndrome (TS)chronic tic disorder
Beyond the preview
Go deeper on NCT01501695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01501695.